Potential Buy opportunities are identified by the price levels at 16.75 / 14.75 (USD)
Bullish Target (Long Term) 34.75
Berkshires average price is likely around 16.50~17
Research
Sector: Pharma
Publically Disclosed February 15 that Berkshire Hathaway bought shares but it is unclear exactly when they purchased 18,875,721 shares of the company when the price averaged around $15. The $357.7 million stake represents 1.86% of the company and merely 0.19% of the portfolio (4th Quarter 2017) In another 2017 development, Teva suspended its dividend. A cessation of shareholder payouts, dire results and heavy debt prompted the market to run from the stock.
TEVA develops, manufactures and sells generic medicine in a range of forms including tablets, capsules, injectables, inhalants, liquids, oitments and creams. They also create specific specialty medicines that assist the Central Nervous System and Respiratory medicines focused on asthma and chronic obstructive pulmonary disease. One of their primary drugs is Copaxone.. used to treat multiple sclerosis however we are seeing more and more generic competition come into the marketplace
Teva’s new Chief Executive Officer Kare Schultz laid out a vast cost-cutting plan in December, halting dividend payments and eliminating 25% of the global workforce. He has repeatedly stated that his biggest priority is to curb the company’s $31.4 billion debt pile..
Other Resources
www.forbes.com/sites...-cheap-and-troubled/
Announcement of new asthma drug
www.streetinsider.co...erosol/13831565.html
Trading can contain substantial risk and is not suited for every investor. An investor could potentially lose all or more than their initial investment. "Risk capital" - is money that can be lost without jeopardizing ones financial security or life style. Only "risk capital" should be used for trading and only those with sufficient risk capital should consider trading. I am not a licensed financial advisor nor do I give out financial advice. You assumes full risk and responsibility for their trading activity. Past performance is not indicative of future results. Individual results will vary due to a variety of market and timing conditions.
Bullish Target (Long Term) 34.75
Berkshires average price is likely around 16.50~17
Research
Sector: Pharma
Publically Disclosed February 15 that Berkshire Hathaway bought shares but it is unclear exactly when they purchased 18,875,721 shares of the company when the price averaged around $15. The $357.7 million stake represents 1.86% of the company and merely 0.19% of the portfolio (4th Quarter 2017) In another 2017 development, Teva suspended its dividend. A cessation of shareholder payouts, dire results and heavy debt prompted the market to run from the stock.
TEVA develops, manufactures and sells generic medicine in a range of forms including tablets, capsules, injectables, inhalants, liquids, oitments and creams. They also create specific specialty medicines that assist the Central Nervous System and Respiratory medicines focused on asthma and chronic obstructive pulmonary disease. One of their primary drugs is Copaxone.. used to treat multiple sclerosis however we are seeing more and more generic competition come into the marketplace
Teva’s new Chief Executive Officer Kare Schultz laid out a vast cost-cutting plan in December, halting dividend payments and eliminating 25% of the global workforce. He has repeatedly stated that his biggest priority is to curb the company’s $31.4 billion debt pile..
Other Resources
www.forbes.com/sites...-cheap-and-troubled/
Announcement of new asthma drug
www.streetinsider.co...erosol/13831565.html
Trading can contain substantial risk and is not suited for every investor. An investor could potentially lose all or more than their initial investment. "Risk capital" - is money that can be lost without jeopardizing ones financial security or life style. Only "risk capital" should be used for trading and only those with sufficient risk capital should consider trading. I am not a licensed financial advisor nor do I give out financial advice. You assumes full risk and responsibility for their trading activity. Past performance is not indicative of future results. Individual results will vary due to a variety of market and timing conditions.
